Sponsor Pipeline

Zhejiang Wenda Pharma Technology LTD. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06527300
A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and…		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07672561 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the… Moderate to Severe Plaque Psoriasis Recruiting
Phase 2
NCT06912165 A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis Brief Description of Focus of Study Recruiting
Phase 1
NCT06897813 A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending… Healthy Participants Not Yet Recruiting
Disease Areas
Psoriasis (1)
Get alerts when Zhejiang Wenda Pharma Technology LTD.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free